Related Experiment Video
Updated: Apr 22, 2026
08:36
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
1.4K
A note regarding meta-analysis of sequential trials with stopping for efficacy
1Competence Center for Methodology and Statistics, CRP-Santé, Strassen, Luxembourg.
Pharmaceutical Statistics
|October 10, 2014
Summary
Fixed-effect meta-analyses of sequential trials are unbiased when weighted correctly, even with interim efficacy looks. This consistency holds for single and potentially multiple looks, impacting statistical analysis in clinical research.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Meta-Analysis
Background:
- Sequential clinical trials allow for early stopping based on efficacy or futility.
- Interim analyses in clinical trials can introduce bias into treatment effect estimates.
- Fixed-effect meta-analysis is a common method for synthesizing results from multiple studies.
Purpose of the Study:
- To determine the unbiasedness of fixed-effect meta-analyses of sequential trial data.
- To investigate the impact of interim efficacy looks on meta-analytic estimates.
- To provide a theoretical basis for the validity of meta-analyses with sequential trial data.
Main Methods:
- Utilizing fixed-effect meta-analysis models.
- Analyzing data from sequentially designed clinical trials.
- Applying information-based weighting for trial estimates.
Main Results:
- Fixed-effect meta-analyses of naïve treatment estimates from sequentially run trials are unbiased (or consistent) when trials are weighted by information.
- A simple proof demonstrates the unbiasedness for single interim looks.
- An argument suggests this unbiasedness extends to multiple interim looks.
Conclusions:
- Fixed-effect meta-analysis is a valid statistical approach for synthesizing data from sequential trials with interim analyses.
- Proper weighting by information is crucial for maintaining the integrity of meta-analytic results.
- The findings have implications for the design and analysis of clinical trials and meta-analyses.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
702
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
702
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
412
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
412
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
622
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
622
01:11Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
01:12Hazard Ratio
741
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
741